OTC · AOXG
Aoxing Pharmaceutical Company, Inc.
$0.00$0.00 (0.0%)
Aoxing Pharmaceutical Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
Loading market information…
OTC · VDRM · USD
Stock price, earnings
Quote as of Oct 29, 2026, 07:27 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ViaDerma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ViaDerma, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a topical antibiotic containing tetracycline, effective for treating a broad spectrum of ailments such as cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Beyond its established products, ViaDerma is dedicated to expanding its pipeline, with ongoing development in fields including advanced topical antibiotics, antifungal treatments for toenails, diabetic amputation recovery, general acne, psoriasis, eczema, burn care, anti-aging and wrinkle-reducing formulations, medical cannabis applications, male pattern baldness, skin cancer, erectile dysfunction, and pain management. Established in 2007, the company operated as Décor Products International, Inc. until its renaming to ViaDerma, Inc. in May 2014. Its corporate operations are directed from Marina Del Rey, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Aoxing Pharmaceutical Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
$0.00$0.00 (0.0%)
Real Brands, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
SFLMaven Corp.: Financial Services · Shell Companies.
$0.00-$0.00 (-25.0%)
GelStat Corporation’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
$0.00$0.00 (0.0%)
Link Reservations Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00-$0.00 (-50.0%)
Grapefruit USA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.67% below the high.
$0.00$0.00 (0.0%)
Pazoo, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
4Front Ventures Corp.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
